ZA902602B - Synergistic compositions containing ketanserin - Google Patents
Synergistic compositions containing ketanserinInfo
- Publication number
- ZA902602B ZA902602B ZA902602A ZA902602A ZA902602B ZA 902602 B ZA902602 B ZA 902602B ZA 902602 A ZA902602 A ZA 902602A ZA 902602 A ZA902602 A ZA 902602A ZA 902602 B ZA902602 B ZA 902602B
- Authority
- ZA
- South Africa
- Prior art keywords
- ketanserin
- compositions containing
- synergistic compositions
- synergistic
- containing ketanserin
- Prior art date
Links
- FPCCSQOGAWCVBH-UHFFFAOYSA-N ketanserin Chemical compound C1=CC(F)=CC=C1C(=O)C1CCN(CCN2C(C3=CC=CC=C3NC2=O)=O)CC1 FPCCSQOGAWCVBH-UHFFFAOYSA-N 0.000 title 1
- 229960005417 ketanserin Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000002195 synergetic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33347189A | 1989-04-05 | 1989-04-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA902602B true ZA902602B (en) | 1991-12-24 |
Family
ID=23302937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA902602A ZA902602B (en) | 1989-04-05 | 1990-04-04 | Synergistic compositions containing ketanserin |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0391462A1 (xx) |
| JP (1) | JPH02290823A (xx) |
| KR (1) | KR900017586A (xx) |
| AU (1) | AU5295790A (xx) |
| CA (1) | CA2013801A1 (xx) |
| IL (1) | IL93990A0 (xx) |
| NZ (1) | NZ233122A (xx) |
| PT (1) | PT93654A (xx) |
| ZA (1) | ZA902602B (xx) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5073539A (en) * | 1990-01-22 | 1991-12-17 | Ciba-Geigy Corporation | Transdermal administration of zwitterionic drugs |
| SI9111842A (sl) * | 1991-11-25 | 1998-04-30 | Krka | Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba |
| AU3290397A (en) * | 1996-06-10 | 1998-01-07 | Depomed, Inc. | Gastric-retentive oral controlled drug delivery system with enhanced retention properties |
| SG150534A1 (en) | 2003-11-20 | 2009-03-30 | Janssen Pharmaceutica Nv | 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp- ribose) polymerase inhibitors |
| US7855207B2 (en) | 2003-11-20 | 2010-12-21 | Janssen Pharmaceutica, Nv | 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitors |
| WO2006003147A1 (en) | 2004-06-30 | 2006-01-12 | Janssen Pharmaceutica N.V. | Phthalazine derivatives as parp inhibitors |
| SG154432A1 (en) * | 2004-06-30 | 2009-08-28 | Janssen Pharmaceutica Nv | Quinazolinedione derivatives as parp inhibitors |
| CA2569826C (en) | 2004-06-30 | 2013-07-16 | Janssen Pharmaceutica N.V. | Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
| GB0624082D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril metal salts |
| GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
| ES2381446T3 (es) | 2007-03-08 | 2012-05-28 | Janssen Pharmaceutica, N.V. | Derivado de quinolinona como inhibidores de PARP y TANK |
| EP2215075B1 (en) | 2007-10-26 | 2013-12-11 | Janssen Pharmaceutica, N.V. | Quinolinone derivatives as parp inhibitors |
| HRP20150139T1 (hr) | 2008-03-27 | 2015-05-22 | Janssen Pharmaceutica N.V. | Tetrahidrofenanthridinoni i tetrahidrociklopentakinolinoni kao inhibitori parp i polimerizacije tubulina |
| AU2009228945B2 (en) | 2008-03-27 | 2013-05-02 | Janssen Pharmaceutica Nv | Quinazolinone derivatives as tubulin polymerization inhibitors |
| SI23149A (sl) * | 2009-09-21 | 2011-03-31 | Silverstone Pharma | Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni |
| CN109157507A (zh) * | 2018-09-14 | 2019-01-08 | 上海禾丰制药有限公司 | 酒石酸酮色林注射液及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3633496A1 (de) * | 1986-10-02 | 1988-04-14 | Hoechst Ag | Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln |
-
1990
- 1990-03-27 EP EP90200719A patent/EP0391462A1/en not_active Withdrawn
- 1990-03-28 NZ NZ233122A patent/NZ233122A/xx unknown
- 1990-04-03 IL IL93990A patent/IL93990A0/xx unknown
- 1990-04-03 KR KR1019900004563A patent/KR900017586A/ko not_active Withdrawn
- 1990-04-03 JP JP2087645A patent/JPH02290823A/ja active Pending
- 1990-04-04 PT PT93654A patent/PT93654A/pt not_active Application Discontinuation
- 1990-04-04 CA CA002013801A patent/CA2013801A1/en not_active Abandoned
- 1990-04-04 ZA ZA902602A patent/ZA902602B/xx unknown
- 1990-04-05 AU AU52957/90A patent/AU5295790A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT93654A (pt) | 1990-11-20 |
| KR900017586A (ko) | 1990-12-19 |
| NZ233122A (en) | 1991-10-25 |
| CA2013801A1 (en) | 1990-10-05 |
| EP0391462A1 (en) | 1990-10-10 |
| AU5295790A (en) | 1990-10-11 |
| JPH02290823A (ja) | 1990-11-30 |
| IL93990A0 (en) | 1991-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL98463A0 (en) | Synergistic antimalarial composition containing benflumetol | |
| IL98177A0 (en) | Synergistic compositions containing tgf-beta | |
| ZA902602B (en) | Synergistic compositions containing ketanserin | |
| ZA892564B (en) | Imazalil containing synergistic compositions | |
| KR950013915B1 (en) | Synergistic surfactant compositions | |
| GB9012993D0 (en) | Dental compositions | |
| GB8904862D0 (en) | Compositions | |
| HU900135D0 (en) | New harbicid compositions | |
| ZA906084B (en) | Biocidal compositions | |
| SG27894G (en) | Injectable compositions containing 25-cyclohexyl-avermectin B1 | |
| ZA908514B (en) | Filme-forming compositions | |
| GB8927010D0 (en) | Compositions | |
| GB8902894D0 (en) | Compositions | |
| GB9009572D0 (en) | Compositions | |
| GB8909729D0 (en) | Compositions | |
| GB8905512D0 (en) | Filler compositions | |
| IE901217L (en) | Synergistic compositions containing ketanserin | |
| GB8924295D0 (en) | Oral compositions | |
| IE892824L (en) | Synergistic mixture | |
| GB9006022D0 (en) | Synergistic compositions | |
| GB8918570D0 (en) | Sterilising compositions | |
| GB8918569D0 (en) | Sterilising compositions | |
| GB8903989D0 (en) | Compositions | |
| GB8910472D0 (en) | Compositions | |
| GB8927240D0 (en) | Compositions |